Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Tumour biology: senescence in premalignant tumours.

Collado M, Gil J, Efeyan A, Guerra C, Schuhmacher AJ, Barradas M, Benguría A, Zaballos A, Flores JM, Barbacid M, Beach D, Serrano M.

Nature. 2005 Aug 4;436(7051):642.

2.

Oncogene-induced senescence as an initial barrier in lymphoma development.

Braig M, Lee S, Loddenkemper C, Rudolph C, Peters AH, Schlegelberger B, Stein H, Dörken B, Jenuwein T, Schmitt CA.

Nature. 2005 Aug 4;436(7051):660-5.

3.

Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis.

Sarkisian CJ, Keister BA, Stairs DB, Boxer RB, Moody SE, Chodosh LA.

Nat Cell Biol. 2007 May;9(5):493-505.

PMID:
17450133
4.

Senescence in intraductal papillary mucinous neoplasm of the pancreas.

Miyasaka Y, Nagai E, Ohuchida K, Fujita H, Nakata K, Hayashi A, Mizumoto K, Tsuneyoshi M, Tanaka M.

Hum Pathol. 2011 Dec;42(12):2010-7. doi: 10.1016/j.humpath.2011.03.007.

PMID:
21733551
5.

A new mechanism of release from senescence: suppression of p16INK4a by beta-catenin.

Curley DP, Bosenberg MW.

Pigment Cell Melanoma Res. 2008 Feb;21(1):5-6. doi: 10.1111/j.1755-148X.2007.00434.x. No abstract available.

PMID:
18353136
6.

The mutant K-ras oncogene causes pancreatic periductal lymphocytic infiltration and gastric mucous neck cell hyperplasia in transgenic mice.

Brembeck FH, Schreiber FS, Deramaudt TB, Craig L, Rhoades B, Swain G, Grippo P, Stoffers DA, Silberg DG, Rustgi AK.

Cancer Res. 2003 May 1;63(9):2005-9.

7.

Profiling of transcripts and proteins modulated by K-ras oncogene in the lung tissues of K-ras transgenic mice by omics approaches.

Lee S, Kang J, Cho M, Seo E, Choi H, Kim E, Kim J, Kim H, Kang GY, Kim KP, Park YH, Yu DY, Yum YN, Park SN, Yoon DY.

Int J Oncol. 2009 Jan;34(1):161-72.

PMID:
19082487
8.

Lung tumourigenesis in a conditional Cul4A transgenic mouse model.

Yang YL, Hung MS, Wang Y, Ni J, Mao JH, Hsieh D, Au A, Kumar A, Quigley D, Fang LT, Yeh CC, Xu Z, Jablons DM, You L.

J Pathol. 2014 Jun;233(2):113-23. doi: 10.1002/path.4352.

9.

Thrombospondin-1 mediates oncogenic Ras-induced senescence in premalignant lung tumors.

Baek KH, Bhang D, Zaslavsky A, Wang LC, Vachani A, Kim CF, Albelda SM, Evan GI, Ryeom S.

J Clin Invest. 2013 Oct;123(10):4375-89. doi: 10.1172/JCI67465.

10.

Expression of p14ARF, p15INK4b, p16INK4a, and DCR2 increases during prostate cancer progression.

Zhang Z, Rosen DG, Yao JL, Huang J, Liu J.

Mod Pathol. 2006 Oct;19(10):1339-43.

11.

Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints.

Bartkova J, Rezaei N, Liontos M, Karakaidos P, Kletsas D, Issaeva N, Vassiliou LV, Kolettas E, Niforou K, Zoumpourlis VC, Takaoka M, Nakagawa H, Tort F, Fugger K, Johansson F, Sehested M, Andersen CL, Dyrskjot L, Ørntoft T, Lukas J, Kittas C, Helleday T, Halazonetis TD, Bartek J, Gorgoulis VG.

Nature. 2006 Nov 30;444(7119):633-7.

PMID:
17136093
12.

Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras.

Jackson EL, Willis N, Mercer K, Bronson RT, Crowley D, Montoya R, Jacks T, Tuveson DA.

Genes Dev. 2001 Dec 15;15(24):3243-8.

13.

The hamster model of sequential oral oncogenesis.

Vairaktaris E, Spyridonidou S, Papakosta V, Vylliotis A, Lazaris A, Perrea D, Yapijakis C, Patsouris E.

Oral Oncol. 2008 Apr;44(4):315-24. Review.

PMID:
18061531
14.

Genetic and epigenetic alterations in lung tumors from bitransgenic Ki-rasG12C expressing mice.

Floyd HS, Jennings-Gee JE, Kock ND, Miller MS.

Mol Carcinog. 2006 Jul;45(7):506-17.

PMID:
16482519
15.

Analysis of c-ErbB1/epidermal growth factor receptor and c-ErbB2/HER-2 expression in bronchial dysplasia: evaluation of potential targets for chemoprevention of lung cancer.

Merrick DT, Kittelson J, Winterhalder R, Kotantoulas G, Ingeberg S, Keith RL, Kennedy TC, Miller YE, Franklin WA, Hirsch FR.

Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2281-8.

16.

Cancer: crime and punishment.

Sharpless NE, DePinho RA.

Nature. 2005 Aug 4;436(7051):636-7. No abstract available.

PMID:
16079829
17.

Expression of the p16(INK4a) gene product in premalignant and malignant epithelial lesions of the gallbladder.

Lynch BC, Lathrop SL, Ye D, Ma TY, Cerilli LA.

Ann Diagn Pathol. 2008 Jun;12(3):161-4. doi: 10.1016/j.anndiagpath.2007.06.003.

PMID:
18486890
18.

Mutation of the androgen receptor causes oncogenic transformation of the prostate.

Ratliff TL.

J Urol. 2005 Sep;174(3):1149. No abstract available.

PMID:
16094083
19.

MYC synergizes with activated BRAFV600E in mouse lung tumor development by suppressing senescence.

Tabor V, Bocci M, Alikhani N, Kuiper R, Larsson LG.

Cancer Res. 2014 Aug 15;74(16):4222-9. doi: 10.1158/0008-5472.CAN-13-3234.

20.

High expression of ligands for chemokine receptor CXCR2 in alveolar epithelial neoplasia induced by oncogenic kras.

Wislez M, Fujimoto N, Izzo JG, Hanna AE, Cody DD, Langley RR, Tang H, Burdick MD, Sato M, Minna JD, Mao L, Wistuba I, Strieter RM, Kurie JM.

Cancer Res. 2006 Apr 15;66(8):4198-207.

Supplemental Content

Support Center